153 related articles for article (PubMed ID: 22329794)
1. Cumulative incidence of pandemic influenza A (H1N1) 2009 by a community-based serological cohort study in Selenghe Province, Mongolia.
Burmaa A; Tsatsral S; Odagiri T; Suzuki A; Oshitani H; Nymadawa P
Influenza Other Respir Viruses; 2012 Nov; 6(6):e97-e104. PubMed ID: 22329794
[TBL] [Abstract][Full Text] [Related]
2. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
3. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
[TBL] [Abstract][Full Text] [Related]
4. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.
Hsu JP; Zhao X; Chen MI; Cook AR; Lee V; Lim WY; Tan L; Barr IG; Jiang L; Tan CL; Phoon MC; Cui L; Lin R; Leo YS; Chow VT
BMC Infect Dis; 2014 Jul; 14():414. PubMed ID: 25066592
[TBL] [Abstract][Full Text] [Related]
5. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
[TBL] [Abstract][Full Text] [Related]
6. Infection with influenza A(H1N1)pdm09 during the first wave of the 2009 pandemic: Evidence from a longitudinal seroepidemiologic study in Dhaka, Bangladesh.
Nasreen S; Rahman M; Hancock K; Katz JM; Goswami D; Sturm-Ramirez K; Holiday C; Jefferson S; Branch A; Wang D; Veguilla V; Widdowson MA; Fry AM; Brooks WA
Influenza Other Respir Viruses; 2017 Sep; 11(5):394-398. PubMed ID: 28688210
[TBL] [Abstract][Full Text] [Related]
7. Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.
Skowronski DM; Hottes TS; McElhaney JE; Janjua NZ; Sabaiduc S; Chan T; Gentleman B; Purych D; Gardy J; Patrick DM; Brunham RC; De Serres G; Petric M
J Infect Dis; 2011 Jan; 203(2):158-67. PubMed ID: 21288814
[TBL] [Abstract][Full Text] [Related]
8. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.
Veguilla V; Hancock K; Schiffer J; Gargiullo P; Lu X; Aranio D; Branch A; Dong L; Holiday C; Liu F; Steward-Clark E; Sun H; Tsang B; Wang D; Whaley M; Bai Y; Cronin L; Browning P; Dababneh H; Noland H; Thomas L; Foster L; Quinn CP; Soroka SD; Katz JM
J Clin Microbiol; 2011 Jun; 49(6):2210-5. PubMed ID: 21471339
[TBL] [Abstract][Full Text] [Related]
10. Serological response to the 2009 pandemic influenza A (H1N1) virus for disease diagnosis and estimating the infection rate in Thai population.
Lerdsamran H; Pittayawonganon C; Pooruk P; Mungaomklang A; Iamsirithaworn S; Thongcharoen P; Kositanont U; Auewarakul P; Chokephaibulkit K; Oota S; Pongkankham W; Silaporn P; Komolsiri S; Noisumdaeng P; Chotpitayasunondh T; Sangsajja C; Wiriyarat W; Louisirirotchanakul S; Puthavathana P
PLoS One; 2011 Jan; 6(1):e16164. PubMed ID: 21283570
[TBL] [Abstract][Full Text] [Related]
11. Seroepidemiology of pandemic influenza A (H1N1) 2009 virus infections in Pune, India.
Tandale BV; Pawar SD; Gurav YK; Chadha MS; Koratkar SS; Shelke VN; Mishra AC
BMC Infect Dis; 2010 Aug; 10():255. PubMed ID: 20738878
[TBL] [Abstract][Full Text] [Related]
12. Serological analysis of human pandemic influenza (H1N1) in Thailand.
Prachayangprecha S; Makkoch J; Payungporn S; Chieochansin T; Vuthitanachot C; Vuthitanachot V; Theamboonlers A; Poovorawan Y
J Health Popul Nutr; 2010 Dec; 28(6):537-44. PubMed ID: 21261198
[TBL] [Abstract][Full Text] [Related]
13. Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population.
Delangue J; Salez N; Ninove L; Kieffer A; Zandotti C; Seston M; Lina B; Nougairede A; Charrel R; Flahault A; de Lamballerie X
Clin Microbiol Infect; 2012 Feb; 18(2):177-83. PubMed ID: 21635661
[TBL] [Abstract][Full Text] [Related]
14. Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?
Allwinn R; Geiler J; Berger A; Cinatl J; Doerr HW
Med Microbiol Immunol; 2010 May; 199(2):117-21. PubMed ID: 20162304
[TBL] [Abstract][Full Text] [Related]
15. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.
Van Kerkhove MD; Hirve S; Koukounari A; Mounts AW;
Influenza Other Respir Viruses; 2013 Sep; 7(5):872-86. PubMed ID: 23331969
[TBL] [Abstract][Full Text] [Related]
16. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response to influenza A(H1N1)pdm2009 in patients with natural infection and in vaccine recipients in the 2009 pandemic.
Kumagai T; Nakayama T; Okuno Y; Kase T; Nishimura N; Ozaki T; Miyata A; Suzuki E; Okafuji T; Okafuji T; Ochiai H; Nagata N; Tsutsumi H; Okamatsu M; Sakoda Y; Kida H; Ihara T
Viral Immunol; 2014 Oct; 27(8):368-74. PubMed ID: 25211638
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida--November-December, 2009.
Cox CM; Goodin K; Fisher E; Dawood FS; Hamilton JJ; Leparc GF; Gray M; Nelson L; Borse RH; Singleton JA; Reed C; Balish AL; Katz JM; Hopkins RS; Fry AM
PLoS One; 2011; 6(12):e29301. PubMed ID: 22206008
[TBL] [Abstract][Full Text] [Related]
19. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
[TBL] [Abstract][Full Text] [Related]
20. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.
von Kries R; Weiss S; Falkenhorst G; Wirth S; Kaiser P; Huppertz HI; Tenenbaum T; Schroten H; Streng A; Liese J; Shai S; Niehues T; Girschick H; Kuscher E; Sauerbrey A; Peters J; Wirsing von König CH; Rückinger S; Hampl W; Michel D; Mertens T
PLoS One; 2011; 6(9):e23955. PubMed ID: 21915270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
